Sign in

CIK 0001108205

  • Non-accelerated filer
  • Smaller reporting company
Ticker
CRIS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
043505116
Phone
+1 617-503-6500
Business address
128 SPRING STREET, BUILDING C, SUITE 500, LEXINGTON, MA, 02421
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 41 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2017-02-28 Pienta Kenneth Director Grant or award · Non-qualified stock option +120,000 120,000
2016-01-19 Pienta Kenneth Director Grant or award · Non-qualified stock option +50,000 50,000
2015-01-26 Pienta Kenneth Director Grant or award · Non-qualified stock option (right to buy) +25,000 25,000
2014-01-27 Pienta Kenneth Director Grant or award · Non-qualified stock option (right to buy) +25,000 25,000
2013-11-08 Pienta Kenneth Director Purchase +20,000 $2.95 $59K 30,000
2013-09-16 Pienta Kenneth Director Purchase +10,000 $4.37 $44K 10,000
2013-03-28 Pienta Kenneth Director Grant or award · Non-qualified stock option (right to buy) +25,000 25,000

Page 1 of 1 · 7 trades